Russian tennis star Maria Sharapova will find out in the first week of October if her two-year doping ban will be overturned, the Court of Arbitration for Sport on Tuesday.
Sharapova was banned from competitions for two years as of January 26, 2016, after she had admitted taking banned drug Meldonium since 2006 because of various health problems, reports Tass.
Meldonium became a banned substance on January 1, 2016.
Sharapova was banned by the International Tennis Federation after she tested positive for Meldonium at the 2016 Australian Open.
She could not take part in the Summer Olympic Games in Rio de Janeiro.
Sharapova filed an appeal against the decision on her suspension at CAS on June 9 and maintains she had "not tried to use a performance-enhancing substance".
Sharapova is a five-time winner of Grand Slam tournaments. She has also won the Federation Cup and a silver medal at the 2012 London Olympics.
She has won 38 tournaments in the Women's Tennis Association (WTA) tour, including 35 in women's singles.
--IANS
dm/sam/vt
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
